U.S. Department of Health and Human Services
Agency for Healthcare Research and Quality: Advancing Excellence in Health Care
Sign up for a Free Account
Busse JW, Craigie S, Juurlink DN, et al. CMAJ. 2017;189:E659-E666.
Opioid pain medications carry high risk for adverse drug events, and opioid misuse is a growing patient safety concern. This guideline provides recommendations to augment safe prescribing of these high-risk medications for patients with chronic noncancer pain.
Postoperative opioid prescribing and the pain scores on Hospital Consumer Assessment of Healthcare Providers and Systems survey.
Lee JS, Hu HM, Brummett CM, et al. JAMA. 2017;317:2013-2015.
Opioid Overdose as a Patient Safety Problem
Irene Berita Murimi, PhD, MA, and G. Caleb Alexander, MD, MS
New persistent opioid use after minor and major surgical procedures in US adults.
Brummett CM, Waljee JF, Goesling J, et al. JAMA Surg. 2017 Apr 12; [Epub ahead of print].
The opioid crisis: can improving diagnosis help solve the problem?
Carr S. ImproveDx. April 2017;4:1-4.
Predictors of in-hospital postoperative opioid overdose after major elective operations: a nationally representative cohort study.
Cauley CE, Anderson G, Haynes AB, Menendez M, Bateman BT, Ladha K. Ann Surg. 2017;265:702-708.
Prescription opioid exposures among children and adolescents in the United States: 2000–2015.
Allen JD, Casavant MJ, Spiller HA, Chounthirath T, Hodges NL, Smith GA. Pediatrics. 2017;139:e20163382.
Trends in medical and nonmedical use of prescription opioids among US adolescents: 1976–2015.
McCabe SE, West BT, Veliz P, McCabe VV, Stoddard SA, Boyd CJ. Pediatrics. 2017;139:e2016-e2387.
Characteristics of initial prescription episodes and likelihood of long-term opioid use—United States, 2006–2015.
Shah A, Hayes CJ, Martin BC. MMWR Morb Mortal Wkly Rep. 2017;66:265-269.
Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis.
Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. BMJ. 2017;356:j760.
Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs.
Gellad WF, Good CB, Shulkin DJ. JAMA Intern Med. 2017 Mar 13; [Epub ahead of print].
Overdose risk in young children of women prescribed opioids.
Finkelstein Y, Macdonald EM, Gonzalez A, Sivilotti MLA, Mamdani MM, Juurlink DN; Canadian Drug Safety And Effectiveness Research Network (CDSERN). Pediatrics. 2017;139:e20162887.
Opioid-prescribing patterns of emergency physicians and risk of long-term use.
Barnett ML, Olenski AR, Jena AB. N Engl J Med. 2017;376:663-673.
Opioids for pain management in older adults: strategies for safe prescribing.
Davies PS. Nurse Pract. 2017;42:20-26.
Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide.
Oliva EM, Bowe T, Tavakoli S, et al. Psychol Serv. 2017;14:34-49.
Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans.
Lin LA, Bohnert AS, Kerns RD, Clay MA, Ganoczy D, Ilgen MA. Pain. 2017;158:833-839.
Increases in drug and opioid overdose deaths—United States, 2000–2015.
Rudd RA, Seth P, David F, Scholl L. MMWR Morb Mortal Wkly Rep. 2016;65:1445-1452.
Prescription Drug Monitoring Programs: Evidence-based Practices to Optimize Prescriber Use.
Philadelphia, PA: Pew Charitable Trusts and Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University; 2016.
Opioid-Related Inpatient Stays and Emergency Department Visits by State, 2009–2014.
Weiss AJ, Elixhauser A, Barrett ML, Steiner CA, Bailey MK, O'Malley L. HCUP Statistical Brief #219. Rockville, MD: Agency for Healthcare Research and Quality; December 2016.
Healthcare system-wide implementation of opioid-safety guideline recommendations: the case of urine drug screening and opioid-patient suicide- and overdose-related events in the Veterans Health Administration.
Brennan PL, Del Re AC, Henderson PT, Trafton JA. Transl Behav Med. 2016;6:605-612.
National Action Plan for Adverse Drug Event Prevention: recommendations for safer outpatient opioid use.
Ducoffe AR, York A, Hu DJ, Perfetto D, Kerns RD. Pain Med. 2016;17:2291-2304.
Turn the Tide Rx.
United States Office of the Surgeon General.
Inappropriate opioid dosing and prescribing for children: an unintended consequence of the clinical pain score?
Voepel-Lewis T, Malviya S, Tait AR. JAMA Pediatr. 2017;171:5-6.
Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims.
Quinn PD, Hur K, Chang Z, et al. Pain. 2017;158:140-148.
National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012.
Gaither JR, Leventhal JM, Ryan SA, Camenga DR. JAMA Pediatr. 2016;170:1195-1201.
Request for comments on the proposed measures and 2020 targets for the National Action Plan for Adverse Drug Event Prevention: inpatient and outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics.
Federal Register. Washington, DC: Office of Disease Prevention and Health Promotion, US Department of Health and Human Services. October 20, 2016;81:72594-72595.
PSNET: Patient Safety Network
PSNet is produced for the Agency for Healthcare Research and Quality by a team of editors at the University of California, San Francisco with guidance from a prominent Technical Expert/Advisory Panel. The AHRQ PSNet site was designed and implemented by Silverchair.
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364